962-59151-36543 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-07-06
Dose 1 — Pfizer-BioNTech
2022-07-27
Dose 2 — Pfizer-BioNTech
2022-07-29
Registered in v-safe
2022-07-29
Survey response — days 1–6 daily, dose 2, under 3
MedDRA: Respiratory tract congestion — Feeling: Poor · Fever · Sleepiness, Irritability/crying, Loss of appetite · Be unable to work or attend school

Free text: Congestion

MedDRA releases: 2024-11 · check-in free text available
2022-07-30
Survey response — days 1–6 daily, dose 2, under 3
MedDRA: Hand-foot-and-mouth disease — Feeling: Fair · Fever · Sleepiness, Irritability/crying · Be unable to work or attend school

Free text: Diagnosed with had foot mouth

MedDRA releases: 2024-11 · check-in free text available
2022-08-03
Health check-in — day 7, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-10
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-17
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-24
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-31
Health check-in — day 35, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-07
Survey response — day 42, dose 2, under 3
MedDRA: Cough — Feeling: Good

Free text: Light Cough

MedDRA releases: 2024-11 · check-in free text available
2022-10-26
Health check-in — 3 months, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-01-25
Survey response — 6 months, dose 2, under 3
MedDRA: Conjunctivitis, Cough, Gastroenteritis viral — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

MedDRA releases: 2024-11
2023-01-25
Report sent to call center — 6 months, dose 2, under 3
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2023-01-26
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-07-06	Pfizer-BioNTech	No
2	2022-07-27	Pfizer-BioNTech	No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 12 (Under 3) — days 1–6 daily, dose 2, under 3

2022-07-29

Systemic reaction (other): Congestion

2022-07-30

Systemic reaction (other): Diagnosed with had foot mouth

Release 12 (Under 3) — day 42, dose 2, under 3

2022-09-07

Symptoms: Light Cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Conjunctivitis	·	·	✓
SD	Cough	·	·	✓
SD	Gastroenteritis viral	·	·	✓
SRO	Hand-foot-and-mouth disease	·	·	✓
SRO	Respiratory tract congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release